Literature DB >> 11439314

Correlation of sodium-related factors with insulin sensitivity in young, lean, male offspring of hypertensive and normotensive subjects.

Y Ohno1, H Suzuki, H Yamakawa, M Nakamura, Y Kato, T Saruta.   

Abstract

Pioneer studies have proposed that multiple metabolic abnormalities, such as insulin resistance, increased Na(+)-H(+) exchanger activity and abnormal intracellular calcium homeostasis, are frequently associated with a subset of essential hypertensive patients with low plasma renin activity (PRA). However, it is unclear whether insulin resistance is related to the low renin status in the very early phase of genetical hypertension. Besides, there is controversy on the subject of the in vivo effect of acute hyperinsulinaemia on sodium-related factors. We investigated the relationship between sodium-related parameters and insulin sensitivity, and the effects of euglycaemic hyperinsulinaemia on cyclic guanosine monophosphate (cGMP) and atrial natriuretic peptide (ANP) levels in 17 young, lean, normotensive male subjects, who displayed extreme predispositions for the development of hypertension. PRA was significantly lower in the positive than in the negative family history group (P < 0.05). Insulin sensitivity (M-value) was correlated with PRA before euglycaemic hyperinsulinaemic clamping (r = 0.577, P < 0.05), and was also inversely correlated with fractional excretion of sodium (FE(Na)) before clamping (r = -0.51, P < 0.05). Euglycaemic hyperinsulinaemia significantly decreased PRA (P < 0.0001) and increased cGMP (P < 0.05) and ANP levels (P < 0.01). In conclusion, insulin sensitivity may be partially determined by PRA levels and FE(Na) before clamping in young, lean, normotensive male subjects. Acute euglycaemic hyperinsulinaemia decreases PRA, and increases cGMP and ANP levels from the fasting condition.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11439314     DOI: 10.1038/sj.jhh.1001211

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  3 in total

1.  Cardiac natriuretic peptides, obesity, and insulin resistance: evidence from two community-based studies.

Authors:  Abigail May Khan; Susan Cheng; Martin Magnusson; Martin G Larson; Christopher Newton-Cheh; Elizabeth L McCabe; Andrea D Coviello; Jose C Florez; Caroline S Fox; Daniel Levy; Sander J Robins; Pankaj Arora; Shalender Bhasin; Carolyn S P Lam; Ramachandran S Vasan; Olle Melander; Thomas J Wang
Journal:  J Clin Endocrinol Metab       Date:  2011-08-17       Impact factor: 5.958

2.  Effect of Pancreatic Hormones on pro-Atrial Natriuretic Peptide in Humans.

Authors:  Nora E Zois; Dijana Terzic; Kristine Færch; Peter Plomgaard; Jakob S Hansen; Peter Rossing; Jens P Goetze
Journal:  EBioMedicine       Date:  2017-03-01       Impact factor: 8.143

3.  Acute effects of insulin on circulating natriuretic peptide levels in humans.

Authors:  Katherine N Bachmann; Serpil Muge Deger; Aseel Alsouqi; Shi Huang; Meng Xu; Jane F Ferguson; Yan Ru Su; Kevin D Niswender; T Alp Ikizler; Thomas J Wang
Journal:  PLoS One       Date:  2018-05-14       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.